MAGEA3 and gastric cancer: In our previous study, we have identified epitopes from MAGEA3 protein and found that patients with gastric cancer had higher reactivity to these epitopes (28); we also found that MAGEA3 multiepitope vaccine can induce humoral and cellular immune responses in mice (29), so we still believe MAGEA3 is an important target for GC diagnosis and immunotherapy.